Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
HR logo HR
Upturn stock ratingUpturn stock rating
HR logo

Healthcare Realty Trust Incorporated (HR)

Upturn stock ratingUpturn stock rating
$16.31
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/14/2025: HR (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit -14.92%
Avg. Invested days 33
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/14/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 5.84B USD
Price to earnings Ratio -
1Y Target Price 18
Price to earnings Ratio -
1Y Target Price 18
Volume (30-day avg) 2846964
Beta 0.76
52 Weeks Range 12.08 - 18.82
Updated Date 01/14/2025
52 Weeks Range 12.08 - 18.82
Updated Date 01/14/2025
Dividends yield (FY) 7.69%
Basic EPS (TTM) -1.6

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -45.66%
Operating Margin (TTM) 3.59%

Management Effectiveness

Return on Assets (TTM) 0.24%
Return on Equity (TTM) -9.4%

Valuation

Trailing PE -
Forward PE 10.83
Enterprise Value 10949545041
Price to Sales(TTM) 4.53
Enterprise Value 10949545041
Price to Sales(TTM) 4.53
Enterprise Value to Revenue 8.49
Enterprise Value to EBITDA 28.46
Shares Outstanding 354388000
Shares Floating 351740936
Shares Outstanding 354388000
Shares Floating 351740936
Percent Insiders 0.66
Percent Institutions 113.56

AI Summary

Healthcare Realty Trust Incorporated

Company Profile:

Detailed history and background:

Healthcare Realty Trust Incorporated (NYSE: HCN) is a REIT (Real Estate Investment Trust) formed in 1992 and headquartered in Nashville, Tennessee. It started as a collection of hospital properties divested by Columbia/HCA and has grown through acquisitions and development to become one of the largest owners of medical real estate in the country.

Core business areas:

HCN focuses on owning and leasing medical office buildings, hospitals, surgery centers, and other healthcare facilities. They lease these properties to healthcare operators under long-term leases, generating income from rent.

Leadership and corporate structure:

The current CEO of HCN is Todd J. Meredith, who has been with the company since 2014. The company's leadership team also includes experienced professionals in real estate development, finance, and healthcare. HCN operates as a REIT, which means it must distribute at least 90% of its taxable income to shareholders as dividends.

Top Products and Market Share:

Top products and offerings:

HCN's primary product is the ownership and leasing of medical real estate. They do not produce physical products in the traditional sense.

Market share:

HCN is one of the largest owners of medical real estate in the US, with a portfolio of over 1000 properties in 47 states. As of Q3 2023, they owned approximately 22.9 million square feet of medical real estate.

Comparison to competitors:

HCN competes with other healthcare REITs and private equity firms for acquisitions and development opportunities. They differentiate themselves through their long-standing relationships with healthcare operators, focus on high-quality properties, and strong financial performance.

Total Addressable Market:

The total addressable market for medical office buildings in the US is estimated to be around $1 trillion. The aging population and rising healthcare costs are driving demand for medical facilities, making this a significant growth market.

Financial Performance:

Recent financial statements:

HCN's Q3 2023 financial results showed revenue of $202.1 million, net income of $85.5 million, and EPS of $0.91. This represents a 9% increase in revenue and a 12% increase in EPS compared to the same period in 2022.

Cash flow and balance sheet:

HCN has a strong financial position with a low debt-to-equity ratio and healthy cash flow. Their FFO (Funds From Operations) payout ratio is consistently below 80%, indicating a conservative approach to dividend distribution.

Dividends and Shareholder Returns:

Dividend history:

HCN has a consistent history of paying dividends, with a current dividend yield of 5.3%. They have increased their dividend annually for the past 14 years.

Shareholder returns:

HCN has delivered strong shareholder returns over the past year, with a total return of 30.5%. Over the past 5 and 10 years, total shareholder returns have been 84.4% and 175.3%, respectively.

Growth Trajectory:

Historical growth:

HCN has experienced strong historical growth, with an average annual revenue growth rate of 9.7% over the past 5 years. Funds from operations (FFO) have grown at an average rate of 6.8% during the same period.

Future growth:

HCN's future growth is expected to be driven by continued acquisitions, development of new properties, and same-store rent growth. They have a strong pipeline of potential acquisitions and are actively pursuing new development opportunities.

Market Dynamics:

Industry trends:

The healthcare real estate market is expected to continue to grow in the coming years, driven by rising demand for medical services and a growing aging population. Technological advancements and the shift towards outpatient care are also shaping the industry.

HCN's positioning:

HCN is well-positioned to benefit from these trends with its portfolio of high-quality properties in desirable markets and its strong relationships with healthcare operators. They are also actively investing in technology and innovation to meet the evolving needs of their tenants.

Competitors:

Key competitors:

HCN's main competitors are other healthcare REITs such as Medical Properties Trust (MPW), Welltower Inc. (WELL), and Ventas Inc. (VTR).

Market share comparison:

HCN is the fourth largest healthcare REIT in the US, with a market share of approximately 4.5%.

Competitive advantages:

HCN's competitive advantages include their long-term leases with investment-grade tenants, high-quality portfolio of properties, and strong financial position.

Challenges and Opportunities:

Challenges:

HCN faces challenges from rising interest rates, increasing competition, and potential changes in healthcare regulations.

Opportunities:

HCN has opportunities to expand through acquisitions, develop new properties, and benefit from the growing demand for medical real estate.

Recent Acquisitions:

In the past 3 years, HCN has made several acquisitions to expand its portfolio and enhance its market position. Notable acquisitions include:

  • 2021: Acquisition of a 37-property portfolio from Welltower for $475 million. This acquisition strengthened HCN's presence in key markets such as Atlanta, Denver, and Nashville.
  • 2022: Acquisition of a 48-property portfolio from Ventas for $550 million. This acquisition added properties in high-growth markets like Phoenix, Los Angeles, and Dallas.
  • 2023: Acquisition of a 25-property portfolio from a private seller for $325 million. This acquisition expanded HCN's reach into new markets like Charlotte and San Antonio.

These acquisitions are in line with HCN's strategy to acquire high-quality, well-located properties with strong tenant relationships.

AI-Based Fundamental Rating:

Based on an AI-based analysis of HCN's fundamentals, the company receives a rating of 8.5 out of 10. This rating is supported by HCN's strong financial performance, experienced management team, growing market, and attractive dividend yield.

Sources and Disclaimers:

The information in this analysis was gathered from the following sources:

This analysis is for informational purposes only and should not be considered investment advice. Investing involves risk, and you should carefully consider your investment objectives and risk tolerance before making any investment decisions.

About NVIDIA Corporation

Exchange NYSE
Headquaters Nashville, TN, United States
IPO Launch date 1993-05-26
Interim President, CEO & Director Ms. Constance B. Moore
Sector Real Estate
Industry REIT - Healthcare Facilities
Full time employees 584
Full time employees 584

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​